Genomma Lab Internacional. de Balance Sheet Health
Financial Health criteria checks 5/6
Genomma Lab Internacional. de has a total shareholder equity of MX$11.2B and total debt of MX$6.6B, which brings its debt-to-equity ratio to 59.1%. Its total assets and total liabilities are MX$23.5B and MX$12.4B respectively. Genomma Lab Internacional. de's EBIT is MX$3.7B making its interest coverage ratio 4.2. It has cash and short-term investments of MX$1.8B.
Key information
59.1%
Debt to equity ratio
Mex$6.59b
Debt
| Interest coverage ratio | 4.2x |
| Cash | Mex$1.83b |
| Equity | Mex$11.15b |
| Total liabilities | Mex$12.36b |
| Total assets | Mex$23.51b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: GNML.F's short term assets (MX$12.2B) exceed its short term liabilities (MX$6.7B).
Long Term Liabilities: GNML.F's short term assets (MX$12.2B) exceed its long term liabilities (MX$5.6B).
Debt to Equity History and Analysis
Debt Level: GNML.F's net debt to equity ratio (42.7%) is considered high.
Reducing Debt: GNML.F's debt to equity ratio has reduced from 74.3% to 59.1% over the past 5 years.
Debt Coverage: GNML.F's debt is well covered by operating cash flow (39%).
Interest Coverage: GNML.F's interest payments on its debt are well covered by EBIT (4.2x coverage).